RESUMEN
Mucocutaneous diseases associated with systemic symptoms are varied. Since 2014, mucocutaneous syndromes, associated with atypical bacterial infections, have been described as specific entities. Most of them by Mycoplasma pneumoniae and up to 10 percent by Chlamydophila pneumoniae. Differential diagnosis is important because it has clinical implications. We present the case of a 24-year-old patient with extensive mucosal and respiratory compromise, compatible with mucosal respiratory syndrome due to Chlamydophila pneumoniae. Initially managed with NSAIDs, which made it difficult to differentiate from other syndromes with mucocutaneous involvement, which are caused by these drugs. We present the case because of how interesting and challenging the differential diagnosis was.
Asunto(s)
Infecciones por Chlamydophila , Chlamydophila pneumoniae , Humanos , Adulto Joven , Masculino , Infecciones por Chlamydophila/complicaciones , Infecciones por Chlamydophila/diagnóstico , Infecciones por Chlamydophila/tratamiento farmacológico , Diagnóstico Diferencial , SíndromeRESUMEN
Pituitary dependent hyperadrenocorticism (PDH) shows a high morbidity and blindness is one of its complications. Compression of the optic chiasm (OC) by the hypophysis adenoma is one of the causes. Another cause could be due to vascular and metabolic alterations of the PDH. Out of a total of 70 dogs with confirmed diagnosis of PDH, 12/70 showed blindness. In only 2/12 the OC was compromised. Electroretinography in dogs without the OC being compromised showed altered A and B wave patterns. Ophthalmological Doppler showed an alteration of the blood flow only in blind dogs without OC compression. Cortisol concentrations (Co), triglycerides (Tg) and glycaemia (G) were greater in 10 dogs with non-compressive blindness vs. dogs with conserved vision. Loss of vision correlated with the increase in these variables. Blindness in dogs with PDH would be related to changes in retinal blood flow, associated to higher Co, Tg and G concentrations.
Asunto(s)
Hiperfunción de las Glándulas Suprarrenales/veterinaria , Ceguera/veterinaria , Glucemia/fisiología , Enfermedades de los Perros/etiología , Hidrocortisona/sangre , Hipófisis/metabolismo , Hiperfunción de las Glándulas Suprarrenales/sangre , Hiperfunción de las Glándulas Suprarrenales/metabolismo , Animales , Perros , Femenino , Masculino , Vasos Retinianos/fisiología , Triglicéridos/sangreRESUMEN
BACKGROUND: The Female Sexual Function index (FSFI), is a scale designed to evaluate sexuality and diagnose the presence of sexual dysfunction in women. AIM: To apply the FSFI to climacteric women. PATIENTS AND METHODS: The FSFI was applied to 370 healthy women aged between 40 and 59years old (49 +/- 6years) that accompanied patients to public health services in Santiago. RESULTS: Fifty six percent of women were married, 44% were postmenopausal, 6% used hormone replacement therapy, 67% were sexually active, and sexual dysfunction was present in 57% of them. Thirty two percent of women aged between 40 and 44 years and 65% of women aged between 55 and 59 years, had sexual dysfunction (p <0.01). In a logistic regression model, the risk of sexual dysfunction increased among women that perceive having health problems (Odds ratio (OR) 3-9; 95%o confidence intervals (95% CI): 1.1-13-8), women older than 48 years (OR 1.9; 95% CI: 1.1-3-4) and women that gave birth to two or more children (OR 1.8; 95% CI: 1.0-3-1). CONCLUSIONS: Climateric women have high prevalence of sexual dysfunction. Age is its main risk factor.
Asunto(s)
Climaterio , Conducta Sexual/estadística & datos numéricos , Disfunciones Sexuales Fisiológicas/epidemiología , Encuestas y Cuestionarios , Adulto , Factores de Edad , Chile/epidemiología , Estudios Transversales , Femenino , Humanos , Modelos Logísticos , Tamizaje Masivo , Persona de Mediana Edad , Prevalencia , Factores de Riesgo , Disfunciones Sexuales Fisiológicas/diagnósticoRESUMEN
Background: The Female Sexual Function index (FSFI), is a scale designed to evaluate sexuality and diagnose the presence of sexual dysfunction in women. Aim: To apply the FSFI to climacteric women. Patients and methods: The FSFI was applied to 370 healthy women aged between 40 and 59years old (49 ± 6years) that accompanied patients to public health services in Santiago. Results: Fifty six percent of women were married, 44 percent were postmenopausal, 6 percent used hormone replacement therapy, 67 percent were sexually active, and sexual dysfunction was present in 57 percent of them. Thirty two percent of women aged between 40 and 44 years and 65 percent of women aged between 55 and 59 years, had sexual dysfunction (p <0.01). In a logistic regression model, the risk of sexual dysfunction increased among women that perceive having health problems (Odds ratio (OR) 3-9; 95 percento confidence intervals (95 percent CI): 1.1-13-8), women older than 48 years (OR 1.9; 95 percent CI: 1.1-3-4) and women that gave birth to two or more children (OR 1.8; 95 percent CI: 1.0-3-1). Conclusions: Climateric women have high prevalence of sexual dysfunction. Age is its main risk factor.